ALBEMARLE CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B | $3.3B |
| Cost of revenue | $4.5B | $5.3B | $8.4B | $4.2B | $2.3B |
| Gross profit | $668.7M | $62.5M | $1.2B | $3.1B | $998.0M |
| Selling, general & administrative | $550.0M | $618.0M | $910.0M | $524.1M | $441.5M |
| Research and development | $51.4M | $86.7M | $85.7M | $72.0M | $54.0M |
| Operating income | -$367.1M | -$1.8B | $251.9M | $2.5B | $798.4M |
| Interest expense | $207.7M | $165.6M | $116.1M | $123.0M | $61.5M |
| Pretax income | -$552.1M | -$1.8B | $246.7M | $2.4B | $133.6M |
| Income tax expense | $156.9M | $87.1M | $430.3M | $390.6M | $29.4M |
| Net income | -$510.6M | -$1.2B | $1.6B | $2.7B | $123.7M |
| Balance Sheet | |||||
| Current assets | $4.0B | $3.8B | $5.2B | $5.2B | $2.0B |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B | $11.0B |
| Current liabilities | $1.8B | $2.0B | $3.6B | $2.7B | $1.9B |
| Stockholders' equity | $9.5B | $10.0B | $9.4B | $8.0B | $5.6B |
| Cash Flow Statement | |||||
| Cash from operations | $1.3B | $687.9M | $1.3B | $1.9B | $344.3M |
| Depreciation and amortization | $658.7M | $588.6M | $429.9M | $300.8M | $254.0M |
| Stock-based compensation | $40.3M | $32.1M | $36.5M | $30.5M | $20.1M |
| Capital expenditure | $589.8M | $1.7B | $2.2B | $1.3B | $953.7M |
| Free cash flow | $692.5M | -$992.7M | -$828.0M | $646.2M | -$609.4M |
| Dividends paid | $190.5M | $188.5M | $187.2M | $184.4M | $177.9M |
| Impairments | $181.1M | $0 | $0 | $0 | $0 |
Shares outstanding 117.9M · Free float 96.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.